NEW YORK (GenomeWeb News) – Nicholas Naclerio has been named VP of corporate development at Illumina. Naclerio formerly was co-founder and executive chairman of Quanterix. In the new role, he will be responsible for licensing, strategic planning, and acquisitions. He also previously raised money for Boreal Genomics, O-Link Bioscience, and Fluxion Bioscience, and he served as president and CEO of ParAllele BioScience.
NanoString Technologies has tapped Brad Gray to be president and CEO, and Nalini Murdter, to be chief business officer. Gray comes to the company from the diagnostic services division at Genzyme, where he recently was VP of product and business development, and before that he was a management consultant at McKinsey and Company.
Murdter has spent 20 years in the life sciences and clinical diagnostics fields. She most recently was at Agilent Technologies, where she was involved in management, business development, strategy and marketing, acquisitions, alliances, ventures, and other specialties.
"Both executives bring to the team deep knowledge of the life sciences market as well as broad business strategy experience that will be highly valuable as we evaluate the various commercialization and partnering opportunities available to us," William Young, executive chairman of NanoString, said in a statement.
Fred Walder has joined Fluidigm as chief business officer from Thermo Fisher Scientific, where he was most recently senior VP of customer and commercial excellence. At Fluidigm, Walder will run business functions and will develop opportunities for the firm's integrated fluidic circuit-based tools. Walder has been an engineering and scientific associate at Sandia National Laboratories, and he spent a decade at Nicolet Instrument.
WaferGen has appointed Andre Marion, co-founder and former chairman and CEO of Applied Biosystems, and Muneesh Tewari, a faculty member at Fred Hutchinson Cancer Research Center, to serve on its scientific advisory board.
William Shanahan has retired from his spot on the board of directors at Life Technologies, but he will continue to work with the company as a consultant to provide expertise on the consumer products end of the company's business.
Jonathan Sebat will run the new Beyster Center for Molecular Genomics of Neuropsychiatric Diseases at the University of California at San Diego. He previously was a faculty member at Cold Spring Harbor Laboratory, where he was a founding member of the Stanley Center for Psychiatric Genomics. In his new post, he will lead clinicians and scientists studying molecular medicine, cross-disciplinary studies, and advancing the understanding and management of mental illness.
Alison Symington will join the Ontario Genomics Institute as VP of outreach, external stakeholder relations, corporate communications, and educational outreach programs. She will oversee the OGI summer research fellowship programs, teaching prizes, and new partnerships with arts and entertainment industries.
Symington previously was a professor and program coordinator at Seneca College's School of Biological Sciences and Applied Chemistry, and she was a development scientist at Sanofi Aventis.
Gerald Fink, a founding member of the Whitehead Institute at the Massachusetts Institute of Technology, has won the 2010 Genetics Prize of the Peter and Patricia Gruber Foundation for his research in yeast genetics.
The $500,000 prize is awarded by a board of geneticists to honor researchers that advance knowledge and whose research could have a profound impact.
Fink will receive the award and give a lecture at the American Society of Human Genetics annual meeting in November. In a statement, he called the award "a good surprise" and said that it "represents recognition by my peers, which is really the ultimate, because these are the people who understand what I did."
Transgenomic has appointed Brett Frevert, founder of CFO Systems, to serve as CFO as an independent contractor while the company searches for someone to fill the job permanently.
Sirius Genomics has appointed Kamran Alam to serve as senior director of business development. Alam has spent more than 12 years in the biotechnology and medical device industry, holding positions at the Centre for Drug Research and Development, Angiotech Pharmaceuticals, and AnorMed.
Cindy WalkerPeach has joined the Austin Technology Incubator as director of the Bioscience incubator. WalkerPeach formerly was director of corporate business development at Asuragen, worked at Ambion before it spun off Asuragen, and she worked at Cenetron Diagnostics. WalkerPeach is taking over the position from Jessica Hanover, who left the job in March to join Rules-Based Medicine.
Leroy Hood has joined the board of directors at the single-molecule DNA sequencing company Nabsys. Hood is co-founder and president of the Institute for Systems Biology, and he has worked with a number of life sciences companies, including Amgen and Applied Biosystems.
Caitlin Cameron has joined Presage Biosciences as CEO. She previously was CEO of CellNetix, a pathology and laboratory company. Cameron also spent 13 years at AT&T. Thane Kreiner, Presage's former CEO, will continue to serve as a strategic advisor to Presage, the company said.
Ivan Baines has joined the Max Planck Florida Institute as chief scientific facilities officer. He is responsible for the scientific infrastructure at the organization, including establishing and managing the laboratories and scientific services for maximum quality and productivity, and implementing a budget management structure. Baines also will serve on the executive board of directors that oversees the design and operation of the Max Planck Florida Institute. He was most recently one of six directors and the scientific coordinator of the Max Planck Institute of Molecular Cell Biology and Genetics in Dresden.
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.